Treatment responses of procaterol and CD38 inhibitors in an ozone-induced airway hyperresponsiveness mice model

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 8, 2013, Pages 1348-1355

  Deng, Zheng ^a,b   Gao, Zhan Cheng ^c   Ge, Hui Qi ^a,b   Zhang, Liang Ren ^a   Zhou, Jun Jun ^a,b   Zhu, Zhi Peng ^a   Wu, Dong Ying ^a   Sun, Shuang Yong ^a,b   Chen, Lin ^c   Pu, Xiao Ping ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Airway hyperresponsiveness; CD38 inhibitor; Inflammation; Nuclear factor kappaB; Ozone exposure; Procaterol

Indexed keywords

CD38 ANTIGEN; DRUG CARRIER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OZONE; PROCATEROL; PROTEIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; TREATMENT RESPONSE;

EID: 84883199664     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00290     Document Type: Article

References (44)

1. Schelegle ES, Walby WF. Vagal afferents contribute to exacerbated airway responses following ozone and allergen challenge. Respir. Physiol. Neurobiol., 181, 277-285 (2012).
2. Glad JA, Brink LL, Talbott EO, Lee PC, Xu X, Saul M, Rager J. The relationship of ambient ozone and PM(2.5) levels and asthma emergency department visits: possible influence of gender and ethnicity. Arch. Environ. Occup. Health, 67, 103-108 (2012).
3. Sheffield PE, Knowlton K, Carr JL, Kinney PL. Modeling of regional climate change effects on ground-level ozone and childhood asthma. Am. J. Prev. Med., 41, 251-257, quiz, A3 (2011).
4. Kesic MJ, Meyer M, Bauer R, Jaspers I. Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection. PLoS ONE, 7, e35108 (2012).
5. Lin S, Liu X, Le LH, Hwang SA. Chronic exposure to ambient ozone and asthma hospital admissions among children. Environ. Health Perspect., 116, 1725-1730 (2008).
6. Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA Jr, Zangrilli J, Haczku A. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy, 63, 438-446 (2008).
7. Garantziotis S, Li Z, Potts EN, Kimata K, Zhuo L, Morgan DL, Savani RC, Noble PW, Foster WM, Schwartz DA, Hollingsworth JW. Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J. Biol. Chem., 284, 11309-11317 (2009).
8. Li Z, Potts-Kant EN, Garantziotis S, Foster WM, Hollingsworth JW. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. PLoS ONE, 6, e27137 (2011).
9. Kohyama T, Yamauchi Y, Takizawa H, Itakura S, Kamitani S, Desaki M, Kawasaki S, Nagase T. Procaterol inhibits lung fibroblast migration. Inflammation, 32, 387-392 (2009).
10. Huang CH, Chu YT, Kuo CH, Wang WL, Hua YM, Lee MS, Hung CH. Effect of procaterol on Th2-related chemokines production in human monocyte and bronchial epithelial cells. Pediatr. Pulmonol., 45, 977-984 (2010).
11. Dogan S, Deshpande DA, White TA, Walseth TF, Kannan MS. Regulation of CD 38 expression and function by steroid hormones in myometrium. Mol. Cell. Endocrinol., 246, 101-106 (2006).
12. Jude JA, Dileepan M, Subramanian S, Solway J, Panettieri RA Jr, Walseth TF, Kannan MS. miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 303, L460-L468 (2012).
13. Jude JA, Dileepan M, Panettieri RA Jr, Walseth TF, Kannan MS. Altered CD38/Cyclic ADP-Ribose Signaling Contributes to the Asthmatic Phenotype. J. Allergy (Cairo), 2012, 289468 (2012).
14. Jude JA, Solway J, Panettieri RA Jr, Walseth TF, Kannan MS. Differential induction of CD38 expression by TNF-alpha in asthmatic airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 299, L879-L890 (2010).
15. Guedes AG, Jude JA, Paulin J, Kita H, Lund FE, Kannan MS. Role of CD38 in TNF-alpha-induced airway hyperresponsiveness. Am. J. Physiol. Lung Cell. Mol. Physiol., 294, L290-L299 (2008).
16. Dong M, Si YQ, Sun SY, Pu XP, Yang ZJ, Zhang LR, Zhang LH, Leung FP, Lam CM, Kwong AK, Yue J, Zhou Y, Kriksunov IA, Hao Q, Lee HC. Design, synthesis and biological characterization of novel inhibitors of CD38. Org. Biomol. Chem., 9, 3246-3257 (2011).
17. Zhou Y, Ting KY, Lam CM, Kwong AK, Xia J, Jin H, Liu Z, Zhang L, Cheung Lee H, Zhang L. Design, synthesis and biological evaluation of noncovalent inhibitors of human CD38 NADase. ChemMedChem, 7, 223-228 (2012).
18. Wertz IE, Dixit VM. Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol., 2, a003350 (2010).
19. Connor AJ, Laskin JD, Laskin DL. Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp. Mol. Pathol., 92, 229-235 (2012).
20. Cho HY, Morgan DL, Bauer AK, Kleeberger SR. Signal transduction pathways of tumor necrosis factor - Mediated lung injury induced by ozone in mice. Am. J. Respir. Crit. Care Med., 175, 829-839 (2007).
21. Wu W, Samet JM, Peden DB, Bromberg PA. Phosphorylation of p65 is required for zinc oxide nanoparticle-induced interleukin 8 expression in human bronchial epithelial cells. Environ. Health Perspect., 118, 982-987 (2010).
22. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev., 18, 2195-2224 (2004).
23. Kim YL, Kim JE, Shin KJ, Lee S, Ahn C, Chung J, Kim DH, Seong JY, Hwang JI. GbetaL regulates TNFalpha-induced NFkappaB signaling by directly inhibiting the activation of IkappaB kinase. Cell. Signal., 20, 2127-2133 (2008).
24. Feng X, Wang H, Ye S, Guan J, Tan W, Cheng S, Wei G, Wu W, Wu F, Zhou Y. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS ONE, 7, e52782 (2012).
25. An CN, Jiang H, Wang Q, Yuan RP, Liu JM, Shi WL, Zhang ZY, Pu XP. Down-regulation of DJ-1 protein in the ejaculated spermatozoa from Chinese asthenozoospermia patients. Fertil. Steril., 96, 19-23, e2 (2011).
26. Brannan JD, Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front. Physiol., 3, 460 (2012).
27. van den Berge M, Vonk JM, Gosman M, Lapperre TS, Snoeck-Stroband JB, Sterk PJ, Kunz LI, Hiemstra PS, Timens W, Ten Hacken NH, Kerstjens HA, Postma DS. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. Eur. Respir. J., 40, 1098-1105 (2012).
28. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis., 15, 316-328 (2005).
29. Singh M, Dang TN, Arseneault M, Ramassamy C. Role of byproducts of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J. Alzheimers Dis., 21, 741-756 (2010).
30. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff RH, Shore SA, Umetsu DT. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med., 205, 385-393 (2008).
31. 2 terminal kinase inhibitor SP600125. J. Pharmacol. Exp. Ther., 322, 351-359 (2007).
32. Kim DY, Park BS, Hong GU, Lee BJ, Park JW, Kim SY, Ro JY. Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin. Br. J. Pharmacol., 162, 210-225 (2011).
33. North ML, Amatullah H, Khanna N, Urch B, Grasemann H, Silverman F, Scott JA. Augmentation of arginase 1 expression by exposure to air pollution exacerbates the airways hyperresponsiveness in murine models of asthma. Respir. Res., 12, 19 (2011).
34. Davis CW, Dickey BF. Regulated airway goblet cell mucin secretion. Annu. Rev. Physiol., 70, 487-512 (2008).
35. Davis BE, Cockcroft DW. Past, present and future uses of methacholine testing. Expert Rev. Respir. Med., 6, 321-329 (2012).
36. Uzkeser H, Cadirci E, Halici Z, Odabasoglu F, Polat B, Yuksel TN, Ozaltin S, Atalay F. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism. Mediators Inflamm., 2012, 438912 (2012).
37. Lin R, Degan S, Theriot BS, Fischer BM, Strachan RT, Liang J, Pierce RA, Sunday ME, Noble PW, Kraft M, Brody AR, Walker JK. Chronic treatment in vivo with β-adrenoceptor agonists induces dysfunction of airway β(2)-adrenoceptors and exacerbates lung inflammation in mice. Br. J. Pharmacol., 165, 2365-2377 (2012).
38. Tashimo H, Yamashita N, Ishida H, Nagase H, Adachi T, Nakano J, Yamamura K, Yano T, Yoshihara H, Ohta K. Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness. Allergol. Int., 56, 241-247 (2007).
39. Ikezono K, Kamata M, Mori T. Adrenal influences on the inhibitory effects of procaterol, a selective beta-two-adrenoceptor agonist, on antigen-induced airway microvascular leakage and bronchoconstriction in Guinea pigs. Pharmacology, 73, 209-215 (2005).
40. Mangunnegoro H, Novariska F, Wiyono WH, Setiawati A, Louisa M. The efficacy of nebulized procaterol versus nebulized salbutamol for the treatment of moderate acute asthma: a randomized, double-blind, parallel group study. Int. J. Clin. Pharmacol. Ther., 49, 614-621 (2011).
41. Yamaya M, Nishimura H, Hatachi Y, Yoshida M, Fujiwara H, Asada M, Nakayama K, Yasuda H, Deng X, Sasaki T, Kubo H, Nagatomi R. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Eur. J. Pharmacol., 650, 431-444 (2011).
42. 2+ overload. Biochem. Biophys. Res. Commun., 399, 167-172 (2010).
43. Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM, Walseth TF, Lee HC. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science, 262, 1056-1059 (1993).
44. Smyth LM, Bobalova J, Mendoza MG, Lew C, Mutafova-Yambolieva VN. Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. J. Biol. Chem., 279, 48893-48903 (2004).